Health Related Quality of Life in stem cell transplantation: Clinical and psychometric validation of the questionnaire module, High Dose Chemotherapy (HDC-19)

References

• Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A. EBMT activity survey 2004 and changes in the disease indication over the past 15 years. Bone Marrow Transplant 2006; 37: 1069–85
   PubMedGoogle Scholar
• Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, Einsele H, et al. Allogeneic and autologous transplantation for haematological diseases, solid tumors and immune disorders: Definition and current practice in Europe. Bone Marrow Transplant 2006; 37: 439–49
   PubMed Web of Science ®Google Scholar
• Bakitas WM. Blood and marrow stem-cell transplantation. Indications, procedure, process, D Wujcik. Jones & Bartlett Publishers, Sudbury 1997
   Google Scholar
• Sanders JE. Chronic graft-versus-host disease and late effects after hematopoetic stem cell transplantation. Int J Hematol 2002; 76(Suppl 2)15–28
   PubMedGoogle Scholar
• Tabbara IA, Zimmerman K, Morgan C, Nahleh Z. Allogeneic hematopoetic stem cell transplantation: Complications and result. Arch Intern Med 2002; 162: 1558–66
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N, et al. The European organisation for research and treatment of cancer: A quality-of-life instrument for use in international clinical trials in oncology. I Natl Cancer Inst 1993; 85: 365–76
   PubMed Web of Science ®Google Scholar
• Muldon M, Barger J, Manuck S. What are quality of life measurements measuring?. BMJ 1998; 316: 542–5
   PubMedGoogle Scholar
• Sprangers M. Quality of life assessment in oncology. Acta Oncol 2002; 41: 229–37
   PubMed Web of Science ®Google Scholar
• Bjordal K, Ahlner-Elmqvist M, Tollesson EA, Razavi D, Maher E, Kaasa S. Development of a European organisation for research and treatment of cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. Acta Oncol 1994; 33: 879–85
   PubMed Web of Science ®Google Scholar
• Blazeby JM, Alderson D, Winstone K, Steyn R, Hammerlid E, Arraras J, et al. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. Eur J Cancer 1996; 32: 1912–7
   Google Scholar
• Sprangers M, Groenvold M, Arras J, Franklin J, te Velde A, Muller M, et al. The EORTC breast-cancer specific quality-of-life questionnaire (QLQ-BR23): First results from a three-country field study. J Clin Oncol 1996; 14: 2756–68
   PubMed Web of Science ®Google Scholar
• Sprangers M, te Velde A, Aaronson A. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-QR38). Eur J Cancer 1999; 35: 238–47
   PubMed Web of Science ®Google Scholar
• Blazeby JM, Conroy T, Bottomley A, Vickery C, Arrars J, Sezer O on behalf of the European organisation for research and treatment of cancer gastrointestinal and quality of life groups, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO22, to assess quality of life in patients with gastric cancer. Eur J Cancer 2004;40:2260–8.
   PubMed Web of Science ®Google Scholar
• Sprangers M, Cull A, Bjordal K, Groenvold M, Aaronson NK. The European organization for research and treatment of cancer approach to quality of life assessment: guidelines for developing questionnaire modules. Qual Life Res 1993; 2: 287–95
   PubMed Web of Science ®Google Scholar
• Hjermstad M, Holte H, Evensen S, Fayers P, Kaasa S. Do patients who are treated with stem cell transplantation have a health related quality of life comparable to the general population after 1 year?. Bone Marrow Transplant 1999a; 24: 911–8
   PubMed Web of Science ®Google Scholar
• Velikova G, Weis J, Hjermstad M, Kopp M, Morris P, Watson M, et al. The EORTC QLQ-HDC29: A supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. Eur J Cancer 2007; 43: 87–94
   PubMed Web of Science ®Google Scholar
• EORTC Quality of life study group. EORTC QLQ-C30 scoring manual3rd ed. EORTC, Brussels 2001
   Google Scholar
• Gorsuch RL. Factor analysis. Lawrenece Erlbaum Associates, Hillsdale, NJ 1983
   Google Scholar
• Hays RD, Hayashi T, Carson S, Ware JE. User's guide for the multi-trait analysis program (MAP). The Rand Publication series. 1988
   Google Scholar
• Fayers PM, Machin D. Quality of life: Assessment, analysis and interpretation. John Wiley & Sons, ChichesterUK 2001
   Google Scholar
• Altman DG. Practical statistics for medical research. Chapman and Hall, London 1991
   Google Scholar
• Cohen J. Statistical power analysis for the behavioural sciences. Lawrence Earlbaum, Hillsdale, NJ 1988
   Google Scholar
• Edman L, Larsen J, Hägglund H, Gardulf A. Health-related quality of life, symptom distress and sense of coherence in adult survivors of allogenic stem-cell transplantation. Eur Cancer Care 2001; 10: 124–30
   PubMed Web of Science ®Google Scholar
• Molassiotis A, Morris P. Quality of life in patients with chronic myeloid leukaemia after unrelated donor bone marrow transplantation. Cancer Nurs 1999; 22: 340–49
   PubMed Web of Science ®Google Scholar
• Broers S, Kaptein A, Saskia L, Fibbe W, Hengeveld M. Psychological functioning and quality of life following bone marrow transplantation: A 3-year follow-up study. J Psychosom Res 2000; 48: 11–21
   PubMed Web of Science ®Google Scholar
• Hjermstad M, Evensen S, Kvaloy S, Fayers P, Kaasa S. Health-related quality of life 1 year after allogenic or autologous stem-cell transplantation: A prospective study. J Clin Oncol 1999b; 17: 706–18
   PubMed Web of Science ®Google Scholar
• Hjermstad M, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, et al. A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation. Bone Marrow Transplant 2004; 34: 257–66
   PubMed Web of Science ®Google Scholar